https://www.selleckchem.com/pr....oducts/propionyl-l-c
Most of these donors (10/12 [83%]) exhibited central nervous system-related symptoms prior to death and 5/23 (22%) infected recipients died. For 11 different donors, prophylaxis, most often with fluconazole, was administered to 23/35 (65.7%) recipients. Clinicians should maintain awareness of donor-derived cryptococcosis and consider prompt prophylaxis or treatment followed by reporting to OPTN for further investigation.Mitochondria have emerged as important targets for cisplatin in cancer therapy. Apart from
Like
Comment
Share
